New “GPS nanoparticle” delivers a genetic punch to the protein implicated in tumor spread

No­var­tis on Tues­day nabbed an­oth­er in­di­ca­tion for its bi­o­log­ic Cosen­tyx (se­cuk­inum­ab), this time in the grow­ing field of treat­ments tar­get­ing the skin con­di­tion hidradeni­tis sup­pu­ra­ti­va

Af­ter years of qui­et fo­cus on HIV and vi­rol­o­gy and sto­ic re­spons­es to flare-ups of at­ten­tion over its pric­ing de­ci­sions, the new Gilead Sci­ences is